Acro Biomedical (ACBM) Net Income towards Common Stockholders (2016 - 2025)
Acro Biomedical (ACBM) recorded quarterly Net Income towards Common Stockholders of $42526.0 in Q4 2025, up 136.1% quarter-over-quarter from -$117809.0 in Q3 2025, and up 498.44% on a YoY basis from $7106.1 in Q4 2024.
Acro Biomedical (ACBM) Net Income towards Common Stockholders (2016 - 2025) Analysis & Trends
Acro Biomedical's Net Income towards Common Stockholders history runs 10 years deep, the most recent figure standing at $42526.0 for Q4 2025.
- In Q4 2025, Net Income towards Common Stockholders rose 498.44% year-over-year to $42526.0; the TTM figure through Dec 2025 stood at -$101146.0 (down 139.13% YoY), while the FY2025 annual figure was -$101146.0, down 139.13% from the prior year.
- Net Income towards Common Stockholders was $42526.0 for Q4 2025 at Acro Biomedical, up from -$117809.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $42526.0 in Q4 2025 to a low of -$4.0 million in Q3 2022.
- Historically, Net Income towards Common Stockholders has averaged -$1.6 million across 5 years, with a median of -$456248.0 in 2021.
- The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders tumbled 6503.69% in 2022, then soared 498.44% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$3.8 million in 2021, then slipped by 2.21% to -$3.9 million in 2022, then surged by 99.54% to -$18240.0 in 2023, then jumped by 41.49% to -$10673.0 in 2024, then jumped by 498.44% to $42526.0 in 2025.
- The last three Net Income towards Common Stockholders figures came in at $42526.0 (Q4 2025), -$117809.0 (Q3 2025), and -$15562.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 3.12 Mn |
| 2 | Berto Acquisition | 312.16 Mn | 312.16 Mn | - | 443,750.00 |
| 3 | Centurion Acquisition | 311.79 Mn | 311.79 Mn | - | 2.02 Mn |
| 4 | Churchill Capital Corp IX | 309.64 Mn | 309.64 Mn | - | 1.49 Mn |
| 5 | WEN Acquisition | 308.55 Mn | 308.55 Mn | - | 537,812.00 |
| 6 | Agriculture & Natural Solutions Acquisition | 304.08 Mn | 304.08 Mn | - | -612,993.00 |
| 7 | Bold Eagle Acquisition | 274.25 Mn | 274.25 Mn | - | 382,994.00 |
| 8 | Soulpower Acquisition | 265.17 Mn | 265.17 Mn | - | 2.95 Mn |
| 9 | BTC Development | 263.21 Mn | 263.21 Mn | - | 1.28 Mn |
| 10 | Acro Biomedical | - | - | - | 42,526.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42,526.00 |
| Sep 30, 2025 | -117,809.00 |
| Jun 30, 2025 | -15,562.00 |
| Mar 31, 2025 | -10,301.00 |
| Dec 31, 2024 | -10,673.00 |
| Sep 30, 2024 | -10,229.00 |
| Jun 30, 2024 | -10,143.00 |
| Mar 31, 2024 | -11,252.00 |
| Dec 31, 2023 | -18,240.00 |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -3.20 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -3.93 Mn |
| Sep 30, 2022 | -4.01 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.85 Mn |
| Sep 30, 2021 | -2.99 Mn |
| Jun 30, 2021 | -794,687.00 |
| Mar 31, 2021 | -59,494.00 |